Group 1 - The company will hold its first extraordinary general meeting of 2026 on January 28, 2026, at 14:40 [2][61] - The meeting will take place at the company's headquarters in Jiangsu Province [2][61] - Shareholders can vote through the Shanghai Stock Exchange's online voting system on the day of the meeting [3][5] Group 2 - The company plans to continue using up to RMB 150 million of temporarily idle raised funds for cash management, focusing on safe and liquid financial products [23][29] - The decision to use idle funds was approved by the board on January 9, 2026, and is valid for 12 months [24][35] - The company aims to enhance the efficiency of fund usage and increase returns for shareholders [28][34] Group 3 - The company has decided to terminate the 2024 restricted stock incentive plan due to changes in the macroeconomic environment and market conditions [41][59] - The termination of the plan includes the cancellation of 1,590,600 shares that were granted but not vested [45][59] - The board believes that this decision will not adversely affect the company's daily operations or shareholder interests [48][51]
江苏康为世纪生物科技股份有限公司关于召开2026年第一次临时股东会的通知